Elizabeth Ellis¹, Lauren Gochenaur¹, Helena Temkin-Greener², Jean Joseph¹, Divya Ajay¹

Canadian Journal of Urology, Vol.30, No.1, pp. 11438-11444, 2023

Abstract Introduction: Due to COVID-19, telemedicine has become a common method of healthcare delivery. Our goal was to evaluate urology patients’ satisfaction with telemedicine, examine patient preferences, and identify opportunities for improvement in readiness, access, and quality of care.
Materials and methods: A total of 285 adult urology patients who completed at least one telemedicine visit from September to December 2020 were eligible. A paper survey was disseminated by postal mail with an option to complete electronically. Those who returned completed surveys received a $15 gift card.
Results: Seventy-six subjects completed the survey (response rate of 27%). The most… More >

Steven P. Rowe^1,2,3, Andrew F. Voter^1,4, Rudolf A. Werner^1,5, Katherine A. Zukotynski^6,7,8, Martin G. Pomper^1,2,3, Michael A. Gorin⁹, Lilja B. Solnes^1,3

Canadian Journal of Urology, Vol.30, No.1, pp. 11432-11437, 2023

Abstract Prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) is rapidly becoming widely accepted as the standard-of-care for imaging of men with prostate cancer. Labeled indications for regulatoryapproved agents include primary staging and recurrent disease in men at risk of metastases. The first commercial PSMA PET agent to become available was 18F-DCFPyL (piflufolastat F 18), a radiofluorinated small molecule with high-affinity for PSMA. The regulatory approval of 18F-DCFPyL hinged upon two key, multi-center, registration trials, OSPREY (patient population: highrisk primary staging) and CONDOR (patient population: biochemical recurrence). In this manuscript, we will (1) review key findings More >

Adel Arezki^1,*, Iman Sadri^1,*, Ahmed S. Zakaria², Felix Couture³, David-Dan Nguyen⁴, Pierre Karakiewicz⁵, Dean S. Elterman⁶, Kevin C. Zorn²

Canadian Journal of Urology, Vol.30, No.1, pp. 11424-11431, 2023

Abstract Introduction: This study aims to report age-stratified potency outcomes in men undergoing robot-assisted radical prostatectomy (RARP).
Materials and methods: A retrospective review was performed on a database of 1737 patients who underwent RARP for localized prostate cancer between 2007 and 2019. Inclusion criteria consisted of patients undergoing bilateral nerve-sparing RARP. Exclusion criteria were preoperative Sexual Health Inventory for Men (SHIM) score < 17 and postoperative androgen deprivation therapy or radiotherapy. Patients were divided into four cohorts based on age: ≤ 54 years (group 1); 55-59 years (group 2); 60-64 years (group 3) and ≥ 65 years (group… More >

Samuel Otis-Chapados, Thomas de los Reyes, Ahmad Mousa, Gagan Fervaha, Sidney B. Radomski

Canadian Journal of Urology, Vol.30, No.1, pp. 11419-11423, 2023

Abstract Introduction: To determine whether larger artificial urinary sphincters (AUS) cuff sizes of ≥ 5.0 cm have an impact on urinary incontinence after AUS implantation as compared to cuff sizes ≤ 4.5 cm.
Materials and methods: A retrospective chart review of AUS implants performed at our institution from 1991 to 2021. Medical records were reviewed for demographics including body mass index (BMI), cause of incontinence, pelvic radiation, valsalva leak point pressure (VLPP), degree of leakage preoperatively and at 1-year post-AUS surgery, AUS revisions, erosion rate and the need for adjunct medication postoperatively.
Results: A total of 110 patients were… More >

Eric Robinson¹, Alex Wang², Solange Bassale³, Jyoti D. Chouhan²

Canadian Journal of Urology, Vol.30, No.1, pp. 11414-11418, 2023

Abstract Introduction: To evaluate the effectiveness of a standardized multimodal pain pathway for gender affirming orchiectomy (GAO) in adequately addressing postoperative pain while reducing the prescribing of unnecessary opioids.
Materials and methods: A standardized discharge pain pathway for GAO +/- scrotectomy or testicular implants was implemented between May 2020 and March 2022. A retrospective analysis was performed on all consecutive patients who underwent GAO with a single surgeon. Patients answered five questions on postoperative pain management at their 3 week follow up.
Results: A total of 69 patients were included in the study. Mean age was 34.3 years (SD… More >

Alexis E. Te¹, Christina Sze¹, Steven A. Kaplan², Bilal Chughtai¹

Canadian Journal of Urology, Vol.30, No.1, pp. 11408-11413, 2023

Abstract Introduction: A common indication for benign prostate hyperplasia (BPH) therapies is failure to improve with medical therapy. However, pivotal Federal Drug Administration (FDA) registered randomized clinical trials (RCTs) for minimally invasive surgical therapies (MISTs) are designed to be compared to either sham or placebo while off medical therapy at baseline, and as an alternative to medical therapy. There are few if any RCTs reporting the MISTS efficacy in patients with true medical therapy failure. We report on the efficacy of robotic water jet ablation therapy (RWT) and TURP in patients who have failed to improve with… More >

Kate H. Moore

Canadian Journal of Urology, Vol.30, No.1, pp. 11407-11407, 2023

Abstract This article has no abstract. More >

Pramod C. Sogani

Canadian Journal of Urology, Vol.30, No.1, pp. 11404-11406, 2023

Abstract This article has no abstract. More >

Kevin R. Loughlin

Canadian Journal of Urology, Vol.30, No.1, pp. 11402-11403, 2023

Abstract This article has no abstract. More >

Matthew J. Rabinowitz, James L. Liu, Jason A. Levy, William DuComb, Arthur L. Burnett

Canadian Journal of Urology, Vol.30, No.2, pp. 11516-11519, 2023

Abstract The artificial urinary sphincter (AUS) is the “gold standard” surgical treatment for severe stress urinary incontinence. However, a subset of patients with frail urethras may require technical adjuncts to ensure optimal cuff function. Our objective is to provide a detailed tutorial of our institution’s method for performing urethral bulking with native tissue in patients with frail urethras during AUS surgery. We have found that urethral bulking with native tissue provides a cost-efficient and durable technique for improved AUS cuff coaptation. Our experience demonstrates adequate short and intermediate term efficacy with limited complications. These techniques equip More >